Position in CADL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$177,933
New position
Shares Held
36,313
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026AlphaCentric Advisors LLC holds $25,792,014 across 49 Biotechnology names. CADL ranks #40 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,931 | $2,201,888 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
19,587 | $1,470,787 | |
| 3 | INSM |
INSMED Inc
|
8,874 | $1,451,076 | |
| 4 | INCY |
Incyte Corp
|
14,245 | $1,340,739 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
47,667 | $1,320,375 | |
| 6 | ARGX |
Argenx SE
|
1,794 | $1,310,068 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
6,438 | $1,088,150 | |
| 8 | ASND |
Ascendis Pharma A/S
|
4,526 | $1,035,231 |
All Filings in CADL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $177,933 | 36,313 | Shares | Other | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||